Found 5 matching trials
Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine
PHASE2The purpose of this study is to determine whether SF2a-TT15 (a monovalent s...
Location
University of Maryland, Baltimore, Center for Vaccine Development and Global Health
Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
PHASE2The purpose of this study is to determine whether CVD 1208S (a live, attenu...
Location
University of Maryland, Baltimore Center for Vaccine Development
Controlled Human Infection Model Challenge/Rechallenge
PHASE1The goal of this study is to better understand Shigella immunity. The study...
Location
Center for Immunization Research (CIR) at Johns Hopkins School of Public Health (JHSPH)
Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb
PHASE2The purpose of this study is to determine whether CVD 1208S (a live, attenu...
Location
Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility
Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
PHASE1The purpose of this study is to select a safe and immunogenic dose of Invap...
Location
Center for Immunization Research (CIR) John Hopkins Bayview Medical Center